Ritchie J L, Cobb L A, Harker L A
J Lab Clin Med. 1979 Feb;93(2):310-5.
Platelet survival times were measured in 11 ambulatory patients within 5 to 21 months of out-of-hospital ventricular fibrillation unassociated with acute myocardial infarction. The mean platelet survival time of 7.7 +/- 2.1 days was shortened when compared with 28 normal controls of similar age (9.0 +/- 1.0 days, p less than 0.03) but not different from 56 other patients with stable angina pectoris (6.85 +/- 1.81 days, p less than 0.2). One patient with a near normal survival time of 7.5 days experienced recurrent ventricular fibrillation without associated acute myocardial infarction 1 month following the platelet survival study. Although one platelet inhibitory agent, sulfinpyrazone, may lower the incidence of sudden cardiac death following acute myocardial infarction, the shortened platelet survival time in the group of patients experiencing out-of-hospital ventricular fibrillation did not distinguish them from others with coronary artery disease.
对11例非院内心室颤动且与急性心肌梗死无关的门诊患者,在院外心室颤动发生后5至21个月内测量了血小板存活时间。与28名年龄相仿的正常对照者(9.0±1.0天,p<0.03)相比,这11例患者的平均血小板存活时间缩短为7.7±2.1天,但与56例其他稳定型心绞痛患者(6.85±1.81天,p<0.2)无差异。在血小板存活时间研究1个月后,1例血小板存活时间接近正常(7.5天)的患者在无急性心肌梗死的情况下发生了复发性心室颤动。尽管一种血小板抑制剂磺吡酮可能会降低急性心肌梗死后心源性猝死的发生率,但在经历院外心室颤动的患者组中,缩短的血小板存活时间并未使他们与其他冠心病患者区分开来。